SUMMARY Changes in platelet a2 adrenoreceptors and their relation to plasma catecholamine concentrations were studied in 11 patients with acute transmural myocardial infarction. A radiolabelled a2 adrenoreceptor antagonist, [3H]-yohimbine, was used to assay x2 adrenoreceptors on platelet membranes, and plasma catecholamine concentrations were measured by high performance liquid chromatography. The number of platelet a2 adrenoreceptors, the dissociation constant, and plasma noradrenaline and adrenaline concentrations were studied 6-6 (3 3) (mean (SD)) hours after the onset of acute myocardial infarction and one month later. The mean (SD) number of adrenoreceptors increased significantly from 94'5 (50'5) fmol/mg protein immediately after infarction to 157-0 (65 7) fmol/mg protein one month later. The dissociation constant, however, did not change significantly (4 33 (1-40) nmol/l vs 437 (1-22) nmol/l). Raised noradrenaline (5-60 (4 37) nmol/l) and adrenaline (0-28 (0 14) nmol/l) concentrations had fallen significantly to normal values (1 21 (0 67) and 0 09 (0 05) nmol/l respectively) a month after infarction. The decrease in the number of a2 adrenoreceptors soon after infarction may be beneficial because such a change will reduce the strength of various reactions to catecholamines, such as vasoconstriction.
Human platelets have been used to investigate the possible role of a2 adrenoreceptors in disease because they are easily obtained and their membranes contain a2 adrenoreceptors.' In patients with angina pectoris the number of platelet a2 adrenoreceptors was reported to be significantly lower when patients had symptoms than when they did 2 not. The number ofa2 adrenoreceptors did not correlate with plasma noradrenaline concentrations. Changes in the number of a2 adrenoreceptors in acute myocardial infarction have not been studied. This is likely to be an important factor because OC2 adrenoreceptors may affect coronary artery tone.
We used a radioligand binding technique to study Blood was drawn from an antecubital vein immediately after admission (6-6 (3-3) hours after the onset of chest pain). Three patients (cases 1, 5, and 9) were initially in Forrester haemodynamic subset II and eight were in subset I. Patients in group I were given frusemide which improved their haemodynamic condition. Blood samples were taken a month after the onset of infarction. All medication was discontinued for at -least 24 hours before the second blood samples were collected.
Platelet membranes were obtained by the method of Garcia-Sevilla et al.3 Blood (30-40 ml) was collected in acid citrate dextrose (8:1, vol/vol). The sample was centrifuged at 160g for 10 minutes at 25°C, and the platelet rich plasma was titrated to pH 6-5 with the acid citrate dextrose solution. Plasma was then recentrifuged at 5100g for 15 minutes at 25°C to obtain a platelet pellet. The pellet was washed twice by 5ml of Tyrode's buffer (sodium chloride 137 mmol/l, potassium chloride 2-7 mmol/l, monobasic sodium phosphate 046 mmol/l, magnesium chloride 0-01 mmol/l, sodium bicarbonate 12-0 mmol/l, dextrose 0-56 mmol/l, pH 8-0) and recentrifuged for 15 min at 5100g. The pellet was lysed by homogenisation in 3 ml of ice cold hypotonic buffer (TRIS edetic acid 5 mmol/l, pH 7-5).
The platelet membranes were obtained by centrifugation at 39 000g for 10 min and then resuspended in the TRIS incubation buffer (TRIS-hydrochloric acid 50 mmol/l, magnesium chloride 10 mmol/l, pH 7-5) used in the radioligand binding assay. RADIOLIGAND 
were raised immediately after infarction, but they had fallen significantly one month later (noradrenaline from 5-60 (4 37) nmol/l to 1-21 (067) nmol/l, p <005; adrenaline from 0-28 (0 14) nmol/l to 009 (0 05) nmol/l, p <0'05). Changes in receptor number and concentrations of noradrenaline and epinephrine were not significantly correlated (noradrenalirle r=0-588, adrenaline r=0 10, both NS).
Discussion
Alpha adrenergic stimulation has been shown to modulate coronary artery tone in dogs and patients with ischaemic heart disease.A-0 Alpha2 adrenoreceptors play an important role in the coronary vasoconstriction elicited by sympathetic nerve stimulation and in regulating the tone of both large and small coronary arteries.9 Thus alterations inC2 adrenoreceptors might affect the coronary artery tone. In patients with symptomatic angina Weiss et al found a decrease in platelet c2 adrenoreceptor number that did not correlate with plasma catecholamine concentrations.2 These findings raise the possibility that x2 adrenoreceptor abnormalities may be associated with the pathogenesis of angina. There is, however, little information on the changes in a2 adrenoreceptors in myocardial infarction. We found that soon after infarction the number of platelet a2 adrenoreceptors was significantly lower than it was one month later. There was no alteration in affinity.
This decrease in receptor number soon after infarction was accompanied by an increase in the plasma catecholamine concentrations.
In an experimental study plasma catecholamines increased rapidly within one minute of coronary occlusion." This increase was considered to reflect enhanced release of noradrenaline from the postganglionic sympathetic nerve endings in the heart. 12 Adrenaline secretion from the adrenal medulla was reflexly induced by stimulation of cardiac receptors at the site and the boundary of the infarct.'2 The increase in plasma catecholamine concentrations was also demonstrated early in myocardial infarction in a previous clinical investigation. 13 In the present study, catecholamine concentrations were significantly raised 6X6 (3 3) hours after infarction. The increase in our study, however, was less pronounced than that observed in previous investigations.' 2 13 This might be due to our excluding patients with cardiogenic shock or severe heart failure, which are both conditions that enhance sympathoadrenal responses. 13 Receptor down regulation is believed to occur when the cell is exposed for some time to higher concentrations of an agonist. The results of experimental studies of down regulation of platelet M2 adrenoreceptor are controversial.14 15 Previous clinical studies found an inverse relation between plasma catecholamine concentrations, especially noradrenaline concentrations, and the number of a2 adrenoreceptors in various conditions such as pheochromcytoma,6 17 congestive heart failure,'8 and idiopathic orthostatic hypotension.'6 This suggests agonist induced down regulation as a possible underlying mechanism. Our results resemble these clinical investigations. The correlation between changes in the receptor number and catecholamine concentrations was not, however, statistically significant. Furthermore, the affinity of the receptor for catecholamines is much higher than the ranges of physiological concentrations.'9 Therefore, it appears unlikely that down regulation of platelet a2 adrenoreceptor occurs in vivo.
Some unknown mechanisms other than down regulation may be involved in the modulation of the receptor number. Further investigations are necessary to clarify the mechanisms which regulate a2 adrenoreceptor in vivo. In any event this decrease in the receptor number when catecholamine concentrations are raised during the early phases of acute infarction may be beneficial because it may moderate catecholamine induced reaction such as vasoconstriction.
